The rise of synthetic opioids and a record supply and demand for other drugs have worsened the global drug problem. This has led to increased drug use disorders and environmental harm, according to the World Drug Report 2024 by the UN Office on Drugs and Crime (UNODC).
ALARMING TRENDS IN DRUG USE
“Drug production, trafficking, and use continue to exacerbate instability and inequality, while causing untold harm to people’s health, safety, and well-being,” said Ghada Waly, Executive Director of UNODC. “We need to provide evidence-based treatment and support to all people affected by drug use, while targeting the illicit drug market and investing much more in prevention.”
In 2022, 292 million people used drugs, a 20% increase over the past decade. Cannabis remains the most widely used drug worldwide with 228 million users. This is followed by opioids (60 million), amphetamines (30 million), cocaine (23 million), and ecstasy (20 million).
Also Read 321,566 Children Lost a Parent to Drug Overdose in a Decade
THE RISE OF SYNTHETIC OPIOIDS
Nitazenes, a group of synthetic opioids more potent than fentanyl, have emerged in several high-income countries, leading to a spike in overdose deaths.
Despite an estimated 64 million people worldwide suffering from drug use disorders, only one in eleven receives treatment. Women have even less access, with only one in eighteen women in treatment compared to one in seven men.
Also Read Record Cocaine Production: Rising Violence
LEGAL AND CRIMINAL JUSTICE ISSUES
In 2022, 7 million people had formal contact with police for drug offenses, mostly due to drug use or possession. Additionally, 2.7 million were prosecuted, and over 1.6 million were convicted globally. The criminal justice response varies significantly across regions.
The report includes special chapters on the impact of the opium ban in Afghanistan, synthetic drugs and gender, the effects of cannabis legalization, the psychedelic renaissance, the right to health in relation to drug use, and drug trafficking in the Golden Triangle.
DRUG TRAFFICKING AND ORGANIZED CRIME
Drug traffickers in the Golden Triangle are diversifying into other illegal activities, including wildlife trafficking, financial fraud, and illegal resource extraction. These activities harm displaced, poor, and migrant communities, sometimes forcing them into opium farming or illegal resource extraction.
Environmental degradation through deforestation, toxic waste dumping, and chemical contamination is a significant concern.
COCAINE PRODUCTION SURGE
A record 2,757 tons of cocaine was produced in 2022, a 20% increase from 2021. Global cultivation of coca bush rose by 12% to 355,000 hectares. This surge has coincided with increased violence along the supply chain, notably in Ecuador and Caribbean countries, and increased health harms in destination countries, including Western and Central Europe.
IMPACT OF CANNABIS LEGALIZATION
By January 2024, Canada, Uruguay, and 27 U.S. jurisdictions had legalized cannabis for non-medical use. This has accelerated harmful use and diversified cannabis products, many with high THC content. Hospitalizations related to cannabis use disorders and psychiatric disorders, including suicide attempts, have increased in Canada and the U.S., especially among young adults.
THE PSYCHEDELIC RENAISSANCE
Interest in the therapeutic use of psychedelics for mental health disorders is growing. However, there are no scientific guidelines for their medical use. The popular “psychedelic renaissance” has led to increased commercial interest and broad access to unsupervised, quasi-therapeutic, and non-medical use of psychedelics. This outpaces scientific evidence and guidelines, potentially compromising public health.
AFGHANISTAN’S OPIUM BAN
Afghanistan’s opium production dropped by 95% in 2023, while Myanmar’s production increased by 36%, leading to a 74% global decrease. Afghan farmers are now poorer, while traffickers are richer. Long-term effects on heroin purity, a switch to other opioids by heroin users, and increased demand for opiate treatment services may soon be felt in countries affected by Afghan opiates.
THE RIGHT TO HEALTH FOR DRUG USERS
The report emphasizes that the right to health is an internationally recognized human right, regardless of drug use status. This right applies equally to people who use drugs, their families, and their communities.
“New” Synthetics
· Cychlorphine: This is the most urgent threat as of March 2026. Detected in major cities like Chicago and Knoxville, this synthetic opioid is estimated to be 10 times stronger than fentanyl. Because it is so new, many standard hospital toxicology screens do not yet detect it.
· Nitazenes: Often referred to as “ISO” or “Frankenstein” drugs, these synthetic opioids were never approved for medical use. They can be up to 40 times more potent than fentanyl and 1,000 times more potent than morphine. Recent wastewater testing in cities like New Orleans has shown a significant surge in nitazene presence following major public events.
· Medetomidine: This is an ultra-potent animal tranquilizer (similar to but much stronger than Xylazine/Tranq). It is increasingly being found in the illicit supply, causing “deep sedation” that Narcan cannot reverse, making overdose response much more difficult.
Public Health Impact
- Skyrocketing Mortality: In the U.S., synthetic opioid-involved death rates increased by 1,040% between 2013 and 2019.
- Rapid Overdose Onset: While a heroin overdose may take 20–30 minutes to become fatal, a fentanyl overdose can cause life-threatening respiratory arrest within 2–5 minutes.
- Treatment Challenges: Because these drugs bind so strongly to brain receptors, standard doses of Naloxone (Narcan) may be insufficient. Responders often need to administer multiple doses or higher-concentration versions (like the 8mg nasal spray) to successfully reverse an overdose.
- Shift in Usage: There has been a significant national decrease in injection drug use, with a corresponding rise in smoking and snorting synthetic opioids, particularly in the Western U.S.
